搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
pharmaphorum
23 小时
Diversity in STEM in 2024: A reflection and a path forward
Looking ahead, the momentum gained in 2024 must be maintained and amplified. By fostering a culture of belonging in the ...
pharmaphorum
1 天
Generative AI in pharma: Moving beyond hype and into widespread adoption
Embedded heuristics and decision-making: In pharma, many decisions are guided by both data and heuristics (i.e., rules of ...
pharmaphorum
1 天
Amid BIOSECURE Act speculation, WuXi AppTec sells unit
The transaction – announced on Christmas Eve – comes after WuXi AppTec has been thrust into the US political spotlight as a ...
pharmaphorum
1 天
Being loud
My conclusion, having worked in various regions and corporate settings: don’t be loud. Be yourself. Be decent. Be ...
pharmaphorum
1 天
PhRMA said to be donating $1m to Trump inauguration
The Pharmaceutical Research and Manufacturers of America (PhRMA) trade body is donating $1 million to fund President-elect ...
pharmaphorum
4 天
Daiichi and AZ pull Dato-DXd filing in Europe too
Preliminary results from TROPION-Lung05 reported at the main ESMO congress last year revealed an overall response rate (ORR) ...
pharmaphorum
10 天
UnitedHealth killing suspect gets first-degree murder charge
First-degree murder charges are applied when there is suspicion of premeditated, intentional killing, while second-degree ...
pharmaphorum
4 天
FDA approves flurry of drugs ahead of holiday season
The task ahead of Vertex now is to migrate patients already on Trikafta to the new drug. That is supported by data from the ...
pharmaphorum
10 天
Lilly's Alzheimer's drug Kisunla is cleared in China
China is the fourth major market where Kisunla has been approved after the US, Japan, and GB. It gets the green light there ...
pharmaphorum
3 天
Where do we stand with clinical trial digitalisation?
Artificial intelligence, machine learning models, automation, connected devices, cloud data storage, intuitive study ...
pharmaphorum
9 天
A new GLP-1 opportunity for pharma: Supporting patients’ emotional barriers to weight loss
Despite their remarkable efficacy for many populations, GLP-1s have a relatively low persistence rate over time, due to a ...
pharmaphorum
4 天
Transforming autoimmune disease therapy: Post-ACR 2024 perspectives on cell therapies
The 2024 American College of Rheumatology (ACR) annual meeting spotlighted transformative advancements in cell therapies for ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈